Medpace Holdings (MEDP) Non-Current Assets (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Non-Current Assets came in at $1.0 billion in Q2 2026, down 4.18% YoY from $1.1 billion in Q2 2025, and up 1.65% on a QoQ basis from $990.6 million in Q1 2026.
Medpace Holdings (MEDP) Non-Current Assets (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Non-Current Assets data on file, last reported at $1.0 billion in Q2 2026.
- Quarterly Non-Current Assets fell 4.18% year-over-year to $1.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.0 billion (down 5.9% YoY) and the FY2025 annual result came in at $985.8 million, down 8.01% from the prior year.
- Non-Current Assets advanced to $1.0 billion in Q2 2026, from $990.6 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.1 billion in Q1 2025 to a low of $985.8 million in Q4 2025.
- A 5-year average of $1.0 billion and a median of $1.0 billion in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets grew 7.67% — and 2025, when it retreated 8.01%.
- Tracing MEDP's Non-Current Assets over 5 years: stood at $1.0 billion in 2022, then rose by 4.37% to $1.1 billion in 2023, then climbed by 0.81% to $1.1 billion in 2024, then retreated by 8.01% to $985.8 million in 2025, then advanced by 2.14% to $1.0 billion in 2026.
- The last three Non-Current Assets figures came in at $1.0 billion (Q2 2026), $990.6 million (Q1 2026), and $985.8 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 89.81 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 78.99 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 998.55 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 8.30 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.66 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 1.93 Bn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 3.82 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 2.32 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 14.72 Bn |
| 10 | Medpace Holdings | 17.20 Bn | 16.70 Bn | 201.64 Mn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Bn |
| Mar 31, 2026 | 990.56 Mn |
| Dec 31, 2025 | 985.85 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 1.05 Bn |
| Mar 31, 2025 | 1.08 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 1.05 Bn |
| Mar 31, 2024 | 1.05 Bn |
| Dec 31, 2023 | 1.06 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 1.03 Bn |
| Dec 31, 2022 | 1.02 Bn |
| Sep 30, 2022 | 990.68 Mn |
| Jun 30, 2022 | 986.57 Mn |
| Mar 31, 2022 | 988.38 Mn |
| Dec 31, 2021 | 969.02 Mn |
| Sep 30, 2021 | 935.92 Mn |